Home › Small Cell Lung Cancer
Small Cell Lung Cancer clinical trials recruiting in the U.S.
97 studies for Small Cell Lung Cancer are recruiting participants at sites across the United States.
Cities with the most studies
- Houston, TX25 studies
- Arlington, VA23 studies
- Boston, MA21 studies
- New York City, NY21 studies
- Nashville, TN20 studies
- Los Angeles, CA20 studies
- Orlando, FL15 studies
- Dallas, TX13 studies
- St. Louis, MO13 studies
- Cleveland, OH13 studies
- Chicago, IL12 studies
- Washington, DC12 studies
- Detroit, MI12 studies
- Baltimore, MD11 studies
- San Antonio, TX11 studies
- Philadelphia, PA10 studies
- Seattle, WA10 studies
- Atlanta, GA9 studies
- Edison, NJ9 studies
- Tampa, FL9 studies
- Grand Rapids, MI9 studies
- Queens, NY9 studies
- Indianapolis, IN9 studies
- Durham, NC9 studies
- Omaha, NE9 studies
- Miami, FL8 studies
- Aurora, CO8 studies
- Cedar Rapids, IA8 studies
- Portland, OR8 studies
- Akron, OH8 studies
- Columbus, OH7 studies
- West Valley City, UT7 studies
- Lexington, KY7 studies
- New Haven, CT7 studies
- Cincinnati, OH7 studies
- Louisville, KY7 studies
- Austin, TX7 studies
- Clifton, NJ6 studies
- Madison, WI6 studies
- Ann Arbor, MI6 studies
By state
- Alabama10 studies
- Arizona9 studies
- Arkansas5 studies
- California36 studies
- Colorado16 studies
- Connecticut9 studies
- District of Columbia5 studies
- Florida36 studies
- Georgia12 studies
- Illinois21 studies
- Indiana12 studies
- Iowa8 studies
- Kansas3 studies
- Kentucky15 studies
- Maryland19 studies
- Massachusetts22 studies
- Michigan26 studies
- Minnesota9 studies
- Missouri17 studies
- Nebraska11 studies
- New Jersey17 studies
- New Mexico3 studies
- New York31 studies
- North Carolina16 studies
- Ohio27 studies
- Oklahoma4 studies
- Oregon9 studies
- Pennsylvania15 studies
- South Carolina7 studies
- South Dakota3 studies
- Tennessee24 studies
- Texas40 studies
- Utah11 studies
- Virginia30 studies
- Washington13 studies
- Wisconsin11 studies
Recently updated studies
Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT02146170A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07099898Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease
RecruitingPhase 1
Ages 18 to 120 · All sexes · Updated Sep 28, 2026 · NCT07509034A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RecruitingPhase 1
Ages 19 and older · All sexes · Updated Sep 28, 2026 · NCT06586957Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07476287Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07226999DESTINY-PANTUMOUR04
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT03460977A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07229313Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06047379A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07155174A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07365241Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
RecruitingPhase 1
Ages 18 to 100 · All sexes · Updated Sep 22, 2026 · NCT07006727A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
RecruitingPhase 1
Ages 18 to 120 · All sexes · Updated Sep 22, 2026 · NCT06066138Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07278479A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07488676Study of Trilaciclib and Lurbinectidin
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05578326Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05983432A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07730021Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT04342429BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07625644A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07407933A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07459634Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Sep 17, 2026 · NCT07778316DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT07472517From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.